首页 | 本学科首页   官方微博 | 高级检索  
检索        

胆管癌患者血清IL—6检测意义
引用本文:何贵金,杜怀林,夏振龙,戴显伟,宋柏.胆管癌患者血清IL—6检测意义[J].中国医科大学学报,2001,30(2):145-146.
作者姓名:何贵金  杜怀林  夏振龙  戴显伟  宋柏
作者单位:1. 中国医科大学第二临床学院肝胆外科,
2. 抚顺石油二厂职工医院外科
摘    要:目的:探讨血清白细胞介素-6(interleukin,IL-6)在胆管癌疾病中临床意义。方法:选择30例胆管良性疾病患者,25例胆管癌患者,20例健康者。采用ELISA双抗体夹心法测血清IL-6的水平变化。结果:25例胆管癌患者血清中IL-6水平明显高于胆管良性疾病及健康者(P<0.05),胆管癌手术后血清IL-6水平明显低于手术前,有显著差异(P<0.05)。结论:胆管癌患者血清IL-6水平明显增高,检测血清IL-6可做为诊断胆管癌重要指标。

关 键 词:胆管癌  胆管良性疾病  白细胞介素-6  诊断
修稿时间:2000年1月17日

The Determination of Serum IL-6 in Cholangiocarcinoma Significance
He Guijin,Du Huailin,Xia Zhenlong,Dai Xianwei,Song Bai.The Determination of Serum IL-6 in Cholangiocarcinoma Significance[J].Journal of China Medical University,2001,30(2):145-146.
Authors:He Guijin  Du Huailin  Xia Zhenlong  Dai Xianwei  Song Bai
Abstract:Objective: To explore the clinical significance. Methods: The double-antibody sandwich ELISA technique. Result: The serum interleukin-6(IL-6) levels of patients with cholangiocarcinoma are significantly higher than those in benign biliary disease and normal controls (P<0.05). Conclusion: Serum IL-6 levels of patients with cholangiocarcinoma are significantly increased ,it is one of the important parameters for clinical evaluation in patients of cholangiocarcinoma.
Keywords:cholangiocarcinoma  benign biliary disease  interleukin-6
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号